Prenatal exposure to thyroid drugs may cause birth defects

10/22/2013 | MedPage Today (free registration)

Infants born to mothers who took hyperthyroidism drugs propylthiouracil and methimazole during early pregnancy were more likely to develop birth defects than those born to women in the general population who didn't take the drugs, according to an analysis of data from Denmark. Prenatal exposure to methimazole was linked to more musculoskeletal defects, and neck and facial problems were linked with propylthiouracil. The study was presented at a meeting of the American Thyroid Association.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA